| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
in Inducing Human Dendritic Cell Maturation
Centre d’Immunologie Pierre Fabre, Saint-Julien en Genevois, France
We investigated the effects of different neuropeptides on human
dendritic cells (DC) maturation. Immature DC, derived from monocytes
cultured for 6 days with IL-4 plus GM-CSF, have been exposed to
somatostatin, substance P, or vasoactive intestinal peptide (VIP).
Among these neuropeptides, only VIP induces the production of bioactive
IL-12 and the neoexpression of CD83 on a fraction of the DC population,
with an effect significant at 100 and 10 nM, respectively. These
effects of VIP are dose-dependent, unaffected by polymixin B, and
partly prevented by a VIP receptor antagonist. Although the effects of
VIP alone remain modest, it synergizes with TNF-
to induce DC
maturation. In the presence of a suboptimal concentration of TNF-,
which has no detectable effect on DC by itself, VIP induces the
production of high levels of bioactive IL-12, the neoexpression of CD83
on almost all the DC population (with an effect significant at 10 and
0.1 nM, respectively), and the up-regulation of various adhesion and
costimulatory molecule expression. Moreover, DC exposed to VIP plus a
suboptimal concentration of TNF- are as potent as mature DC obtained
by treatment with an optimal concentration of TNF- in stimulating
allogenic T cell proliferation. Our data suggest that, in inflammatory
sites, VIP may cooperate with proinflammatory mediators, such as
TNF-, to induce DC maturation.
This article has been cited by other articles:
|
|
 |
|
  D. Fabricius, M. S. O'Dorisio, S. Blackwell, and B. Jahrsdorfer Human Plasmacytoid Dendritic Cell Function: Inhibition of IFN-{alpha} Secretion and Modulation of Immune Phenotype by Vasoactive Intestinal Peptide J. Immunol., November 1, 2006; 177(9): 5920 - 5927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ashwood, S. Wills, and J. Van de Water The immune response in autism: a new frontier for autism research J. Leukoc. Biol., July 1, 2006; 80(1): 1 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Delgado, D. Pozo, and D. Ganea The Significance of Vasoactive Intestinal Peptide in Immunomodulation Pharmacol. Rev., June 1, 2004; 56(2): 249 - 290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Delgado, A. Reduta, V. Sharma, and D. Ganea VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4+ T cells J. Leukoc. Biol., June 1, 2004; 75(6): 1122 - 1130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. STRAUB and H. O. BESEDOVSKY Integrated evolutionary, immunological, and neuroendocrine framework for the pathogenesis of chronic disabling inflammatory diseases FASEB J, December 1, 2003; 17(15): 2176 - 2183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Burzyn, C. C. Jancic, S. Zittermann, M. I. Keller Sarmiento, L. Fainboim, R. E. Rosenstein, and H. E. Chuluyan Decrease in cAMP levels modulates adhesion to fibronectin and immunostimulatory ability of human dendritic cells J. Leukoc. Biol., July 1, 2002; 72(1): 93 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Ganea and M. Delgado VASOACTIVE INTESTINAL PEPTIDE (VIP) AND PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AS MODULATORS OF BOTH INNATE AND ADAPTIVE IMMUNITY Critical Reviews in Oral Biology & Medicine, May 1, 2002; 13(3): 229 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ni, J. Capodici, G. Cannon, D. Communi, J.-M. Boeynaems, K. Kariko, and D. Weissman Extracellular mRNA Induces Dendritic Cell Activation by Stimulating Tumor Necrosis Factor-alpha Secretion and Signaling through a Nucleotide Receptor J. Biol. Chem., April 5, 2002; 277(15): 12689 - 12696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Lipscomb and B. J. Masten Dendritic Cells: Immune Regulators in Health and Disease Physiol Rev, January 1, 2002; 82(1): 97 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Stober, R. Schirmbeck, and J. Reimann IL-12/IL-18-Dependent IFN-{{gamma}} Release by Murine Dendritic Cells J. Immunol., July 15, 2001; 167(2): 957 - 965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Wilkin, X. Duhant, C. Bruyns, N. Suarez-Huerta, J.-M. Boeynaems, and B. Robaye The P2Y11 Receptor Mediates the ATP-Induced Maturation of Human Monocyte-Derived Dendritic Cells J. Immunol., June 15, 2001; 166(12): 7172 - 7177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dunzendorfer, A. Kaser, C. Meierhofer, H. Tilg, and C. J. Wiedermann Cutting Edge: Peripheral Neuropeptides Attract Immature and Arrest Mature Blood-Derived Dendritic Cells J. Immunol., February 15, 2001; 166(4): 2167 - 2172. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
